-
公开(公告)号:EP4225366A1
公开(公告)日:2023-08-16
申请号:EP21878555.8
申请日:2021-10-07
IPC分类号: A61K39/39 , A61K47/60 , A61K31/4745 , A61K31/80
-
2.
公开(公告)号:EP4404961A1
公开(公告)日:2024-07-31
申请号:EP22869532.6
申请日:2022-09-20
申请人: Laboratorio Avi-Mex, S.A. De C.V. , Consejo Nacional De Humanidades, Ciencias Y Tecnologías , Icahn School of Medicine at Mount Sinai
-
公开(公告)号:EP4151232A1
公开(公告)日:2023-03-22
申请号:EP21804807.2
申请日:2021-02-22
发明人: LOZANO-DUBERNARD, Bernardo , SOTO-PRIANTE, Ernesto , SARFATI-MIZRAHI, David , CASTRO-PERALTA, Felipa , PAZ-DE LA ROSA, Georgina , PALESE, Peter , GARCIA-SASTRE, Adolfo , KRAMMER, Florian , SUN, Weina
IPC分类号: A61K39/215 , C12N15/86 , A61P31/14
摘要: An active or inactivated recombinant vaccine against COVID-19 is described that comprises a Newcastle disease viral vector and a pharmaceutically acceptable carrier, adjuvant and/or excipient, characterized in that the viral vector is a virus capable of generating a cellular immune response that has a SARS-CoV-2 exogenous nucleotide sequence inserted.
-
4.
公开(公告)号:EP4146674A2
公开(公告)日:2023-03-15
申请号:EP21800838.1
申请日:2021-05-06
IPC分类号: C07K14/165 , C07K14/005
-
5.
公开(公告)号:EP4110803A1
公开(公告)日:2023-01-04
申请号:EP21760173.1
申请日:2021-02-26
发明人: SKOBE, Mihaela , EDWARDS, Andrew, Kenneth , FERNANDEZ-RODRIGUEZ, Ruben , GARCIA-SASTRE, Adolfo , MENA, Ignacio , CUADRADO CASTAÑO, Sara
IPC分类号: C07K14/71 , A61P35/00 , A61K35/768
-
公开(公告)号:EP2536425B1
公开(公告)日:2019-06-19
申请号:EP11745345.6
申请日:2011-02-18
-
公开(公告)号:EP3471767A1
公开(公告)日:2019-04-24
申请号:EP17813990.3
申请日:2017-06-14
IPC分类号: A61K39/12 , A61K39/145 , C07K14/005 , C12N7/00
-
公开(公告)号:EP2987856B1
公开(公告)日:2018-07-25
申请号:EP15162322.0
申请日:2010-02-05
IPC分类号: C12N7/00 , A61K35/76 , C07K14/125 , C07K14/11
CPC分类号: C12N7/00 , A61K35/13 , A61K39/0011 , A61K39/17 , C07K14/005 , C12N2760/16122 , C12N2760/18121 , C12N2760/18122 , C12N2760/18132 , C12N2760/18143 , C12N2760/18171
摘要: The invention provides chimeric Newcastle disease viruses (NDV) engineered to express a heterologous interferon antagonist, a modified F protein, and a cytokine. Further provided are pharmaceutical compositions comprising such chimeric viruses, methods for producing said pharmaceutical compositions and their use in a method for treating cancer in a subject. Provided are also cells and non-human embryonated eggs comprising the chimeric NDV viruses of the invention.
-
公开(公告)号:EP4408977A2
公开(公告)日:2024-08-07
申请号:EP22873913.2
申请日:2022-09-26
IPC分类号: C12N5/0735 , C12N5/02 , C12N15/85
CPC分类号: C12N5/0696 , C12N2501/60220130101 , C12N2501/60320130101 , C12N2501/60420130101 , C12N2501/60620130101 , C12N2506/130720130101 , C12N2501/11520130101 , C12N2501/12520130101 , C12N2501/23520130101 , C12N2533/5420130101 , C12N2502/132320130101 , C12N2513/0020130101 , C12N2501/4220130101 , C12N2501/4120130101 , C12N7/00 , C12N2770/2002120130101 , C12N2770/2005120130101 , C12N2740/1302120130101 , C12N2770/2003420130101 , C12N2770/3612120130101
-
公开(公告)号:EP4161922A1
公开(公告)日:2023-04-12
申请号:EP21822105.9
申请日:2021-06-08
IPC分类号: C07D417/06 , C07D279/14 , C07D279/10 , C07D279/16 , A61P31/14 , A61P31/16
-
-
-
-
-
-
-
-
-